Navigation Links
CRH experiences significant increase in business activity
Date:2/18/2009

VANCOUVER, Feb. 18 /PRNewswire-FirstCall/ - CRH Medical announced today that for the year ended December 31, 2008, it had 27,348 patient visits at its Centers for Colorectal Health compared to 13,461 for the same period in 2007. In addition, as a result of it's Partnership Program, the Company sold 6,840 units of its CRH O'Regan Hemorrhoid Banding Technology compared to 1,920 for the same period in 2007. The Company trained more than 100 physicians in its Partnership Program during the second half of 2008, versus only 9 physicians in 2007.

Commenting on the these results and plans going forward, Edward Wright, Chief Executive Officer, stated, "Although we do not yet have audited financial reports, we anticipate a significant increase in revenue in 2008 versus 2007, as well as a decrease in our losses. We continue to focus on cutting expenses and increasing our activities in our highest margin business segment, our Partnership Program in an attempt, to achieve cash flow positive operations as soon as possible in the current year. We are very excited about the opportunity our Partnership Program provides our partner physicians and their patients."

Through its Partnership Program the Company sells its patented proprietary hemorrhoid banding technology, treatment protocols, marketing and operational experience directly to physicians who see patients that may be in need of hemorrhoid treatment. By adopting the use of the CRH Technology, the physician increases practice revenues, expands the continuum of care and provides a fast, painless hemorrhoid solution to patients.

The Company expects to publish its full 2008 financial and annual report by the end of April, 2009.

About CRH Medical Corporation:

CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I - IV. CRH Medical employs two commercialization strategies: First, it operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening. In addition CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, "turn key" package directly to its partner physicians. The Company's goal is to establish the CRH hemorrhoid technology as the standard for hemorrhoid treatment.

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.

    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this release.


'/>"/>
SOURCE CRH Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Experiences Bring More Joy Than Possessions Do
2. Perceptions and experiences of homeless youth vary by race, UCSF study shows
3. A life with pain -- new study examines the experiences of older people
4. It takes 2 to know 1: Shared experiences change self-recognition
5. Experiences of rape unique to Rwandan women survivors of genocide
6. Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante
7. PaperThin Experiences Record Growth : Grows Revenues, Expands Channel, and Maintains 95%+ Subscription Renewal Rate
8. Racial and ethnic disparities detected in patient experiences
9. Seniors Gain Experiences of a Lifetime
10. Massachusetts Patients Offer Feedback on Their Experiences With Primary Care
11. Authoritative Report on Emergency Department Experiences Released Today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 2016 , ... The Association of Home Care Coding & ... Health and Hospice ICD-10 Transition Workgroup are working closely with the American Hospital ... to address concerns over the use of 'A' as the seventh character indicating ...
(Date:2/8/2016)... ... 08, 2016 , ... Guruji Mahendra Kumar Trivedi is offering 3 days of ... of his birthday on February 10th. During this time, people can achieve better ... over 250,000 people from over 40 different countries as an “ordinary man with an ...
(Date:2/7/2016)... Clarkston, Metamora, Michigan (PRWEB) , ... February 07, ... ... correct pelvic organ prolapse with the latest techniques and the most minimally invasive ... for pelvic organ prolapse, particularly after menopause. Other risk factors include surgery to ...
(Date:2/7/2016)... Scottsdale, AZ (PRWEB) , ... February 07, 2016 ... ... & Neck and Facial Plastics, has added Kybella® to his medical and surgical ... is a newly approved FDA injectable medication used as a non-surgical alternative for ...
(Date:2/6/2016)... ... , ... With the FCPX LUT: Summer pack from Pixel Film ... LUT is a Lookup Table that contains a mathematical formula for modifying an image. ... By manipulating each pixel, LUT's can change each color range differently, it gives the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  Labvantage Lx, a newcomer to the ... sexual enhancement product, EnduramenT. Setting a new standard ... a patented biomedical breakthrough molecule that promotes the ... responsible for many biological functions including erectile function. ... Forgoing the use of prescription medications, scientists working ...
(Date:2/8/2016)... 2016  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... quarter and year-end 2015 results after the Nasdaq market ... host a live conference call and webcast to discuss ... afternoon, February 11, 2016 at 4:30 p.m. Eastern Time ... --> http://www.neurocrine.com . --> Participants can ...
(Date:2/8/2016)... 2016 --> ... "Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, ... Surgery, Ophthalmology, Gynecology) - Global Forecasts to 2020", published ... the forecast period of 2015 to 2020. The market ... CAGR of 10.5% from 2015 to 2020. ...
Breaking Medicine Technology: